Press / Medias

Press / Medias

Special en direct de San Francisco : JP Morgan 2019

Jan 11, 2019

more +
Press / Medias

Christensenella: the key to unlocking gut microbiome-based drug discovery?

Jan 2, 2019

more +
Press / Medias

Cornell patent deal helps LNC ramp-up microbiome therapeutics strategy

Dec 17, 2018

more +
Press / Medias

A Bordeaux, LNC Therapeutics veut développer l’arme absolue contre l’obésité

Oct 26, 2018

more +
Press / Medias

LNC Therapeutics Acquires Exclusive License for the Christensenella Patent from Cornell University

Oct 17, 2018

more +
Press / Medias

LNC Therapeutics lance son nouvel essai clinique, OBEMINALE 2, et traite son premier patient

Oct 10, 2018

more +

LNC Therapeutics © 2019 - all rights reserved terms and conditions